Composition: Pantoprazole 40mg + Domperidone 30mg (SR)
Description
Composition: Pantoprazole 40mg + Domperidone 30mg (SR) (capsules). It combines Pantoprazole (proton pump inhibitor) and Domperidone (prokinetic and antiemetic); each component acts on a different part of the clinical problem.
Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting H+/K+-ATPase. Domperidone is a peripheral dopamine D2 antagonist with prokinetic and antiemetic activity.
AEROPAN-DSR is a prescription medicine from Aerochem Neutron's digestive and GI range, for use on the prescription of a registered medical practitioner.
· Contains Pantoprazole 40mg + Domperidone 30mg (SR)
· Pantoprazole — proton pump inhibitor that suppresses gastric acid secretion by inhibiting H+/K+-ATPase
· Domperidone — peripheral dopamine D2 antagonist with prokinetic and antiemetic activity
· Presented as capsules
· Prescription-only medicine
· Gastro-oesophageal reflux disease (GERD)
· Functional dyspepsia
· Hyperacidity with nausea and vomiting
· Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Long-term PPI use is associated with hypomagnesaemia, vitamin B12 deficiency, bone fracture risk and C. difficile infection; exclude gastric malignancy before treatment.
· Domperidone is associated with QT prolongation and serious ventricular arrhythmias; regulators recommend the lowest effective dose for the shortest duration and avoidance in cardiac disease, hepatic impairment and with CYP3A4 inhibitors.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of pantoprazole described here follow the US prescribing information (DailyMed); the EMA 2014 domperidone review limited its use to relief of nausea and vomiting at the lowest effective dose for the shortest duration because of cardiac risk. Evidence summary for Domperidone: reference verification pending. Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.
References
· DailyMed (US NLM) prescribing information – pantoprazole: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PANTOPRAZOLE
· EMA – Domperidone-containing medicines referral (2014): https://www.ema.europa.eu/en/medicines/human/referrals/domperidone-containing-medicines
· Reference verification pending for: Domperidone
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about AEROPAN DSR for professional use.